Curanex Pharmaceuticals Inc fell 15.3% on Friday, November 13, 2026, on 6,237 shares. No headline about CURX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Curanex Pharmaceuticals Inc (CURX:NASDAQ) closed at $4.80 on November 13, 2026, down 15.34% on the day. The stock trades 64.0% below its 52-week high of $13.34 and 34.1% above its 52-week low of $3.58. Over the past year, it lost 53.8%. Curanex Pharmaceuticals Inc is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, CURX closed higher on 104 days (41%). Its best day was February 26, 2026 (+45.57%) and its worst was April 7, 2026 (-18.53%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 3 times.
Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients' lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.
Find more stocks like CURX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.